1. Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Issue 30 (20th October 2021) Authors: Park, Keunchil; Haura, Eric B.; Leighl, Natasha B.; Mitchell, Paul; Shu, Catherine A.; Girard, Nicolas; Viteri, Santiago; Han, Ji-Youn; Kim, Sang-We; Lee, Chee Khoon; Sabari, Joshua K.; Spira, Alexander I.; Yang, Tsung-Ying; Kim, Dong-Wan; Lee, Ki Hyeong; Sanborn, Rachel E.; Trigo, José; Goto, Ko... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. (April 2023) Authors: Park, Keunchil; Sabari, Joshua K.; Haura, Eric B.; Shu, Catherine A.; Spira, Alexander; Salgia, Ravi; Reckamp, Karen L.; Sanborn, Rachel E.; Govindan, Ramaswamy; Bauml, Joshua M.; Curtin, Joshua C.; Xie, John; Roshak, Amy; Lorenzini, Patricia; Millington, Dawn; Thayu, Meena; Knoblauch, Roland E.;... Journal: Lung cancer Issue: Volume 178(2023) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease. Issue 6 (June 2016) Authors: Stein, Ronen; Lee, Dale; Leonard, Mary B.; Thayu, Meena; Denson, Lee A.; Chuang, Emil; Herskovitz, Rita; Kerbowski, Theresa; Baldassano, Robert N. Journal: Inflammatory bowel diseases Issue: Volume 22:Issue 6(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗